Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cardiac Gene Therapy: Combination Products' Next Frontier?

Sep 01 2003

• By Mark Ratner

Related Content

The Device Angle on Angiogenesis

Sep 01 1999

Gene Therapy Trials and Tribulations

Jan 01 2000

Gene Delivery: Looking Past the Skeptics

Jun 01 2002

Convergent Calling: An Interview with Medtronic's Stephen Oesterle

Sep 01 2003

Edwards: Will a Biotech Deal Strategy Work For a Device Company?

Sep 01 2002

Related Companies

Medtronic plc

Medtronic plc

Novartis AG

BioCardia

Medtronic plc

Boston Scientific Corporation

Cardinal Health, Inc.

Boston Scientific Corporation

Bayer AG

Sanofi

Novartis AG

Merck & Co., Inc.

Genentech, Inc.

GenVec, Inc.

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

St. Michael's Hospital

University of Toronto

Urigen Pharmaceuticals, Inc.

Sanofi Genzyme

University of Pennsylvania

Edwards Lifesciences Corp.

Cook Group, Inc.

Cook Group, Inc.

Sangamo Therapeutics, Inc.

Baxter International Inc.

Baxter International Inc.

Osiris Therapeutics, Inc.

Sanofi

MicroHeart Inc.

AngioSense Inc.

Kansas State University

Harvard University

Dana-Farber/Harvard Cancer Center

Boston Children’s Hospital

Johnson & Johnson

Additional Topics

Strategy Business Strategies Innovation Platform Technologies Regenerative Medicine BioPharmaceutical Medical Device

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window